Medical Marijuana Inc Stock Forecast & Price Prediction 2026-2027

Algorithmic price targets and analysis for MJNA based on fundamentals, valuation multiples, and historical data.

$9.84+3.51%
Neutral

Price Target Summary

Bear Case
$9.13
-7.2% from current
Base Case
$14.65
+48.8% from current
Bull Case
$26.36
+167.9% from current

Technical Outlook

52-Week Range Analysis

$9.61$12.89
Current: $9.84
Support Level
$9.94
Resistance Level
$12.56
From 52W High
-23.7%
From 52W Low
+2.4%

Fundamental Analysis

Revenue Growth Projection

Year 1 Projected
$1.95B
Year 2 Projected
$2.26B
Year 3 Projected
$2.53B

Based on +20.0% YoY growth, tapered 20% per year in outer projections.

Valuation vs Peers

Current P/S
8.64x
Sector Median P/S
2.5x
Assessment
Premium to sector

Cash Position

Cash on Hand
$330.8M
Total Debt
$373.5M
Cash Runway
29 mo

Key Metrics

Current Price$9.84
Market Cap$3.28B
P/S Ratio8.64x
Revenue (TTM)$1.63B
Revenue Growth (YoY)+20.0%
Gross MarginN/A
Cash on Hand$330.8M
Total Debt$373.5M
52W High$12.89
52W Low$9.61

Signal Breakdown

Overall Signal: Neutral
  • Strong revenue growth above 10% YoY
  • Total debt exceeds cash position
  • Elevated P/S ratio relative to sector

Risk Factors

  • Cannabis remains federally illegal in the United States, creating regulatory uncertainty.
  • The cannabis sector is highly competitive with ongoing price compression in many markets.

Analyst Summary

Medical Marijuana Inc (MJNA) is a MSO cannabis company with growing revenue and a market capitalization of $3.28B. Based on trailing revenue of $1.63B and a P/S ratio of 8.64x, the stock trades at a premium relative to the sector median of 2.5x. Our algorithmic base-case price target of $14.65 implies upside of 48.8% from current levels. The overall signal is neutral, with a mixed fundamental picture. Investors should weigh the 2 identified risk factors before making any investment decision.

Frequently Asked Questions

What is the price target for MJNA?+
Our algorithmic base-case price target for Medical Marijuana Inc (MJNA) is $14.65, with a bear case of $9.13 and a bull case of $26.36. These targets are derived from sector-average and premium P/S multiples applied to projected revenue.
Is MJNA a buy right now?+
Based on our algorithmic analysis, MJNA currently carries a neutral signal. Strong revenue growth above 10% YoY. Total debt exceeds cash position. This is not a buy or sell recommendation — always do your own due diligence.
What is the revenue forecast for Medical Marijuana Inc?+
Based on the current year-over-year growth rate of +20.0%, we project MJNA revenue at $1.95B in Year 1, $2.26B in Year 2, and $2.53B in Year 3. Growth rates are tapered in outer years.
What are the risks of investing in MJNA?+
Cannabis remains federally illegal in the United States, creating regulatory uncertainty. The cannabis sector is highly competitive with ongoing price compression in many markets.
How does MJNA valuation compare to the cannabis sector?+
MJNA has a trailing P/S ratio of 8.64x compared to the cannabis sector median of 2.5x. The stock premium to sector.

Important Disclaimer

This is not financial advice. Forecasts are algorithmic projections based on historical data and should not be used as the sole basis for investment decisions. Past performance does not guarantee future results. Cannabis stocks carry significant risk including regulatory, market, and operational risks. Always consult with a qualified financial advisor before making investment decisions. Cannabismarketcap does not recommend buying, selling, or holding any security.

← Back to MJNA OverviewAll Cannabis Stocks